full announcement

05 Feb 2019 08:33 CET

Novo Nordisk files annual report with the SEC

Bagsværd, Denmark, 5 February 2019 - Novo Nordisk A/S has filed its Annual Report 2018 on Form 20-F for the financial year 2018 with the US Securities and Exchange Commission (SEC), incorporating by reference parts of the Novo Nordisk A/S Annual Report 2018. The reports are available at the SEC's website,, as well as on

Shareholders and ADR holders may receive a hard copy of the annual reports free of charge upon request by filling out a request form on or upon request to - please state the exact mailing address and the document(s) you wish to receive.

Further information

Mette Kruse Danielsen +45 4442 3883
Ken Inchausti (US) +1 609 786 8316
Peter Hugreffe Ankersen +45 3075 9085
Anders Mikkelsen +45 3079 4461
Valdemar Borum Svarrer +45 3079 0301
Kristoffer Due Berg +45 3079 2849
Ann Søndermølle Rendbæk +45 3075 2253